We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Sets Tropical Disease Priority Review Voucher Fee at $2.3 Million
FDA Sets Tropical Disease Priority Review Voucher Fee at $2.3 Million
September 4, 2013
Drugmakers will have to pay a $2,325,000 priority review fee when submitting an NDA or BLA with a tropical disease priority review voucher during fiscal 2014, which begins on Oct. 1, 2013.